U.S. Iliac Stents Market Revenue & Forecast Analysis, 2026-2035
The U.S. iliac stents market was evaluated at USD 464.71 million in 2025 and is projected to grow at a CAGR of 6.3% from USD 489.85 million in 2026 to USD 845.97 million in 2035. The market growth is primarily driven by the increasing prevalence of iliac artery occlusive disease and peripheral arterial disease, leading to a higher demand for endovascular interventions to restore blood flow and reduce vascular complications. Furthermore, continuous advancements in stent design and delivery systems, rising preference for minimally invasive vascular procedures, and the growing adoption of image-guided treatment approaches are contributing to the expansion of the U.S. iliac stents market.
Market Overview
According to a 2023 study published in the Journal of Vascular Surgery, a multicenter U.S. study of iliac branch endoprosthesis treatment reported favorable long-term patency and durability outcomes, highlighting the growing clinical adoption of iliac stent technologies for managing complex iliac artery diseases in the United States.
The U.S. iliac stents market has grown steadily over the years, supported by advancements in endovascular treatment technologies, increasing physician preference for minimally invasive vascular procedures, and the growing adoption of stent-based interventions for iliac artery disease. Improvements in stent flexibility, radial strength, and long-term patency have further enhanced clinical utilization. For instance, in March 2023, the U.S. FDA approved the iCast Covered Stent System for iliac artery disease treatment, highlighting ongoing innovation in iliac stent technologies and contributing to market growth.
The U.S. iliac stents market is projected to experience significant growth throughout the forecast period due to the rising burden of peripheral arterial disease, increasing demand for outpatient vascular interventions, and ongoing advancements in image-guided treatment techniques. The growing focus on preserving vessel patency while reducing procedural complications is also supporting market expansion. For instance, by 2035, U.S. vascular centers are expected to expand the adoption of advanced iliac stent solutions to improve long-term treatment outcomes and patient care.
U.S. Iliac Stents Market Overview
Base Year Market Size (2025): USD 464.71 Million
CAGR: 6.3%
Forecast Year Market Size (2035): USD 845.97 Million
Major Players:
Abbott Laboratories
Boston Scientific Corporation
Medtronic plc
W. L. Gore & Associates, Inc.
Cook Medical LLC
U.S. Iliac Stents Market Trends
The U.S. iliac stents market is evolving rapidly due to advancements in vascular imaging technologies, increasing emphasis on long-term procedural outcomes, and the growing adoption of precision-based endovascular treatment strategies.
· The increasing use of intravascular imaging tools during iliac interventions is enhancing lesion assessment and supporting more accurate stent placement decisions.
· The growing preference for covered stents in complex iliac artery lesions is encouraging the adoption of treatment approaches focused on reducing restenosis and improving vessel durability.
· The rising utilization of iliac branch devices for preserving pelvic blood flow during aneurysm repair is expanding the scope of endovascular treatment options.
· The increasing integration of advanced navigation and procedural planning technologies is improving treatment efficiency and supporting personalized vascular care.
Collectively, these trends are expected to support the continued growth of the U.S. iliac stents market by enhancing procedural precision, expanding therapeutic capabilities, and improving long-term patient outcomes.
U.S. Iliac Stents Market Analysis
By Stent Type
Self-expandable Stents dominate the U.S. iliac stents market due to their superior flexibility and vessel conformity
Based on stent type, the U.S. iliac stents market is categorised into self-expandable stents, balloon-expandable stents, and others. The self-expandable stents segment leads the market with the highest market share in 2025.
By Artery Lesions
Common Iliac Artery Lesions dominate the U.S. iliac stents market owing to the high volume of endovascular procedures
Based on artery lesions, the U.S. iliac stents market is categorised into common iliac artery lesions, severe calcified lesions, and complete obstructive lesions. The common iliac artery lesions segment leads the market with the highest market share in 2025.
By Material Type
Nitinol dominates the U.S. iliac stents market due to its durability and shape-memory properties
Based on material type, the U.S. iliac stents market is categorised into nitinol, stainless steel, cobalt-chromium alloys, and covered fabric. The nitinol segment leads the market with the highest market share in 2025.
By End-use
Hospitals dominate the U.S. iliac stents market owing to their advanced vascular intervention capabilities
Based on end-use, the U.S. iliac stents market is categorised into hospitals, outpatient facilities, and others. The hospitals segment leads the market with the highest market share in 2025.
Key Companies Profiled
The U.S. iliac stents market features a competitive landscape with leading medical device manufacturers competing through advanced stent technologies, broad vascular intervention portfolios, and continuous product innovation. Key players such as Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, W. L. Gore & Associates, Inc., and Cook Medical hold a significant share of the market, supported by strong clinical expertise, established distribution networks, and ongoing research and development activities.
The market is highly competitive, with companies focusing on improved stent durability, enhanced deliverability, and advanced endovascular solutions to strengthen their market positions. The increasing demand for minimally invasive vascular procedures, growing prevalence of peripheral arterial disease, and continuous technological advancements in vascular intervention devices are further intensifying competition across the market.
U.S. Iliac Stents Market Companies:
Some of the key companies operating in the U.S. Iliac Stents Market include:
Abbott Laboratories
B. Braun Melsungen AG
Becton, Dickinson and Company (BD)
Biotronik SE & Co. KG
Boston Scientific Corporation
Cook Medical LLC
Cordis Corporation
Endologix LLC
Getinge AB
iVascular S.L.U.
JOTEC GmbH
Medtronic plc
MicroPort Scientific Corporation
Terumo Corporation
W. L. Gore & Associates, Inc.
Market Segmentation
This study provides revenue growth and emerging trends across the U.S. levels from 2021 to 2035, segmenting the U.S. iliac stents market by-
Stent Type (Revenue in USD Million, 2021 - 2035)
Self-expandable Stents
Balloon-expandable Stents
Others
Artery Lesions (Revenue in USD Million, 2021 - 2035)
Common Iliac Artery Lesions
Severe Calcified Lesions
Complete Obstructive Lesions
Material Type (Revenue in USD Million, 2021 – 2035)
Nitinol
Stainless steel
Cobalt-chromium alloys
Covered Fabric
End-use (Revenue in USD Million, 2021 – 2035)
Hospitals
Outpatient Facilities
Others
Table of Content
1. Methodology and Scope
1.1. Scope of the Study
1.1.1. Market Segmentation
1.1.2. Market Definition
1.1.3. Inclusions and Exclusions of the Study
1.2. Research Design
1.2.1. Base Year, Historical Data, and Forecast Period
1.2.2. Data Collection Methods
1.2.2.1. Secondary Sources
1.2.2.2. Primary Sources
1.2.3. Research Methodology
1.2.3.1. Base Year Calculation/ Parent Market Analysis, Company/ Brand Share Analysis, 2025 (Top-down Approach)
1.2.3.2. Volume-Price Approach (Bottom-up Approach)
1.2.3.3. Data Triangulation
1.2.4. Forecasting Model
1.3. Research Assumptions
1.4. Validation and Data Quality Control
1.5. List of Primary Sources
1.6. List of Secondary Sources
2. Executive Summary
2.1. Market Overview
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
3. Industry Outlook
3.1. Industry Ecosystem Analysis
3.2. Parent/ Ancillary Market Analysis
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Restraints/ Challenges
3.3.3. Opportunities
3.4. Value Chain Analysis
3.5. Technology Roadmap
3.6. Porters Analysis
3.7. PESTLE Analysis
4. Market Estimates and Forecasts, By Stent Type, 2021 - 2035 (Market Size in USD Mn)
4.1. Self-expandable Stents
4.2. Balloon-expandable Stents
4.3. Others
5. Market Estimates and Forecasts, By Artery Lesions, 2021 – 2035 (USD Mn)
5.1. Common Iliac Artery Lesions
5.2. Severe Calcified Lesions
5.3. Complete Obstructive Lesions
6. Market Estimates and Forecasts, By Material Type, 2021 – 2035 (USD Mn)
6.1. Nitinol
6.2. Stainless steel
6.3. Cobalt-chromium alloys
6.4. Covered Fabric
7. Market Estimates and Forecasts, By End-use, 2021 – 2035 (USD Mn)
7.1. Hospitals
7.2. Outpatient Facilities
7.3. Others
8. Market Estimates and Forecasts, By U.S., 2021 - 2035 (USD Mn)
8.1.1. U.S.
8.1.1.1. U.S. Iliac Stents Market Estimates and Forecasts to 2035 (USD Mn)
8.1.1.2. Market Dynamics
8.1.1.3. Competitive Landscape
8.1.1.4. Regulatory Framework
8.1.1.5. Reimbursement Scenario
9. Competitive Landscape
9.1. Company Market Share Analysis, 2025
9.2. Company Tier Structure
9.3. List of Major Suppliers, By Key Countries
9.4. Key Company Positioning Analysis
9.5. Company Profile
9.5.1. Abbott Laboratories
9.5.2. B. Braun Melsungen AG
9.5.3. Becton, Dickinson and Company (BD)
9.5.4. Biotronik SE & Co. KG
9.5.5. Boston Scientific Corporation
9.5.6. Cook Medical LLC
9.5.7. Cordis Corporation
9.5.8. Endologix LLC
9.5.9. Getinge AB
9.5.10. iVascular S.L.U.
9.5.11. JOTEC GmbH
9.5.12. Medtronic plc
9.5.13. MicroPort Scientific Corporation
9.5.14. Terumo Corporation
9.5.15. W. L. Gore & Associates, Inc.
10. Analyst Perspective
11. Related Reports
Revolution Insights Briefs
Stay informed with updates on related market reports and key industry topics.